Aptose Biosciences (TSX:APS) Short-Term Capital Lease Obligation : C$0.63 Mil (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Aptose Biosciences Short-Term Capital Lease Obligation?

Aptose Biosciences's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was C$0.63 Mil.

Aptose Biosciences's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 (C$0.56 Mil) to Dec. 2024 (C$0.61 Mil) and increased from Dec. 2024 (C$0.61 Mil) to Mar. 2025 (C$0.63 Mil).

Aptose Biosciences's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (C$0.41 Mil) to Dec. 2023 (C$0.53 Mil) and increased from Dec. 2023 (C$0.53 Mil) to Dec. 2024 (C$0.61 Mil).

Aptose Biosciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Aptose Biosciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Short-Term Capital Lease Obligation Chart

Aptose Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.69

0.59

0.41

0.53

0.61

Aptose Biosciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.54	0.55	0.56	0.61	0.63

Aptose Biosciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Aptose Biosciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptose Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

APTOF:USA 0UI8:UK LTI0:Germany

Address

66 Wellington Street West, Suite 5300, TD Bank Tower Box 48, Toronto, ON, CAN, M5K 1E6

Website

https://www.aptose.com

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Executives

Bernd Robert Seizinger	Director
William Glenn Rice	Director, Senior Officer
Charles Fletcher Payne	Senior Officer
Erich Platzer	Director
Rafael Bejar	Senior Officer
Warren Whitehead	Director
Gregory Kwok Lee Chow	Senior Officer
Jotin Marango	Senior Officer

Aptose Biosciences Headlines

No Headlines